Last reviewed · How we verify

A Randomized, Controlled Trial on Dexmedetomidine for Providing Adequate Sedation and Preserved Neurologic Examination for Endovascular Treatment of Acute Ischemic Stroke or Cerebral Vasospasm.

NCT01845441 Phase 2 TERMINATED Results posted

Dexmedetomidine is a unique sedative medication able to provide sedation without causing respiratory depression and maintaining neurological functions. Patients having an acute ischemic stroke and need to undergo endovascular therapy require constant assessment of their neurological status prior, during and after the interventional procedure. In this study the investigators will compare the efficacy of Dexmedetomidine to other standard sedative medications in providing optimal sedative effect while maintaining neurological function.

Details

Lead sponsorUniversity Hospitals Cleveland Medical Center
PhasePhase 2
StatusTERMINATED
Enrolment7
Start date2012-04
Completion2021-12

Conditions

Interventions

Primary outcomes

Countries

United States